NANOVATE Trademark

Trademark Overview

On Thursday, May 1, 2025, a trademark application was filed for NANOVATE with the United States Patent and Trademark Office. The USPTO has given the NANOVATE trademark a serial number of 99165346. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 1, 2025. This trademark is owned by Interactome Biotherapeutics Inc.. The NANOVATE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biotechnological gene therapy, nucleic acid drug and protein delivery platform technology for loading, targeting, and enhancing secretomes, extracellular vesicles (EVs) and exosomes across gene therapy, RNA medicine, and protein therapeutics

Design, development and operation of gene therapy, nucleic acid drug and protein delivery platform technology for scientific and medical research and development to help pharmaceutical companies deliver proteins, antibodies, small molecule inhibitors, nucleic acid medicines, vaccines, gene silencing and gene editing
nanovate

General Information

Serial Number99165346
Word MarkNANOVATE
Filing DateThursday, May 1, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, May 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiotechnological gene therapy, nucleic acid drug and protein delivery platform technology for loading, targeting, and enhancing secretomes, extracellular vesicles (EVs) and exosomes across gene therapy, RNA medicine, and protein therapeutics
Goods and ServicesDesign, development and operation of gene therapy, nucleic acid drug and protein delivery platform technology for scientific and medical research and development to help pharmaceutical companies deliver proteins, antibodies, small molecule inhibitors, nucleic acid medicines, vaccines, gene silencing and gene editing

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 1, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInteractome Biotherapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Rapids, MI 49512

Trademark Events

Event DateEvent Description
Thursday, May 1, 2025NEW APPLICATION ENTERED
Thursday, May 1, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

nanovate gene protein acid nucleic therapy technology development platform delivery drug